ABO blood group and SARS‐CoV‐2 antibody response in a convalescent donor population
Abstract
ABO blood group may affect risk of SARS‐CoV‐2 infection and/or severity of COVID‐19. We sought to determine whether IgG, IgA and neutralizing antibody (nAb) to SARS‐CoV‐2 vary by ABO blood group.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 25, 2021
- Source ID
- 10.1111/vox.13070
Entities
People
- Aaron Tobian
- Andrew D. Redd
- Andrew Pekosz
- Arturo Casadevall
- Brenda J. Grossman
- Christi Marshall
- David P Sullivan
- Eric A Gehrie
- Eshan U Patel
- Evan M Bloch
- Imani Burgess
- Jeffrey L. Winters
- Kirsten Littlefield
- Oliver Laeyendecker
- Ruchee Shrestha
- Ruchika Goel
- Shmuel Shoham
- Thomas C. Quinn
Organizations
- Bloomberg Philanthropies
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Johns Hopkins Bloomberg School of Public Health
- Johns Hopkins University
- Mayo Clinic
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- United States Department of Defense
- Washington University in St. Louis